Bcl2l12-KO 基因敲除小鼠

1. Wang, Haichuan, Zhang, Shanshan, Zhang, Yi, Zeng, Yong, Chen, Xin. 2021. TAZ is indispensable for c-MYC-induced hepatocarcinogenesis. In Journal of hepatology, 76, 123-134. doi:10.1016/j.jhep.2021.08.021. https://pubmed.ncbi.nlm.nih.gov/34464659/

2. Nikcevic, Gordana, Drazilov, Sanja Srzentic, Djurasevic, Teodora Karan, Scorilas, Andreas, Pavlovic, Sonja. 2020. Complex transcriptional regulation of the BCL2L12 gene: Novel, active promoter in K562 cells. In Gene, 750, 144723. doi:10.1016/j.gene.2020.144723. https://pubmed.ncbi.nlm.nih.gov/32387119/

3. Kladi-Skandali, Athina, Sideris, Diamantis C, Scorilas, Andreas. . BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer. In Clinical chemistry and laboratory medicine, 57, 276-287. doi:10.1515/cclm-2018-0272. https://pubmed.ncbi.nlm.nih.gov/30325729/

4. Adamopoulos, Panagiotis G, Kontos, Christos K, Tsiakanikas, Panagiotis, Scorilas, Andreas. 2016. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology. In Cancer letters, 373, 119-129. doi:10.1016/j.canlet.2016.01.019. https://pubmed.ncbi.nlm.nih.gov/26797417/

5. Stegh, Alexander H, DePinho, Ronald A. 2011. Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma. In Cell cycle (Georgetown, Tex.), 10, 33-8. doi:. https://pubmed.ncbi.nlm.nih.gov/21200141/

6. Papageorgiou, Sotirios G, Kontos, Christos K, Pappa, Vassiliki, Economopoulos, Theofanis, Scorilas, Andreas. 2011. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. In The oncologist, 16, 1280-91. doi:10.1634/theoncologist.2010-0349. https://pubmed.ncbi.nlm.nih.gov/21737576/

7. Kumthekar, Priya, Ko, Caroline H, Paunesku, Tatjana, Horbinski, Craig, Stegh, Alexander H. . A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. In Science translational medicine, 13, . doi:10.1126/scitranslmed.abb3945. https://pubmed.ncbi.nlm.nih.gov/33692132/

8. Tzovaras, Alexandros, Kladi-Skandali, Athina, Michaelidou, Kleita, Ardavanis, Alexandros, Scorilas, Andreas. 2014. BCL2L12: a promising molecular prognostic biomarker in breast cancer. In Clinical biochemistry, 47, 257-62. doi:10.1016/j.clinbiochem.2014.09.008. https://pubmed.ncbi.nlm.nih.gov/25230343/

9. Fendri, Ali, Kontos, Christos K, Khabir, Abdelmajid, Mokdad-Gargouri, Raja, Scorilas, Andreas. 2010. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. In Molecular medicine (Cambridge, Mass.), 17, 163-71. doi:10.2119/molmed.2010.00056. https://pubmed.ncbi.nlm.nih.gov/21152697/

10. Taghavi, Mahdieh Sadat, Akbarzadeh, Azim, Mahdian, Reza, Azadmanesh, Kayhan, Javadi, Gholamreza. 2013. Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells. In In vitro cellular & developmental biology. Animal, 49, 465-72. doi:10.1007/s11626-013-9622-4. https://pubmed.ncbi.nlm.nih.gov/23708917/